288 related articles for article (PubMed ID: 29454619)
1. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABA
Olander ER; Madjroh N; Bunch L; Söderhielm PC; Jensen AA
Biochem Pharmacol; 2018 Apr; 150():305-319. PubMed ID: 29454619
[TBL] [Abstract][Full Text] [Related]
2. The Influence of AA29504 on GABA
Sikstus S; Benkherouf AY; Soini SL; Uusi-Oukari M
Neurochem Res; 2022 Mar; 47(3):667-678. PubMed ID: 34727270
[TBL] [Abstract][Full Text] [Related]
3. Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABA
Madjroh N; Olander ER; Bundgaard C; Söderhielm PC; Jensen AA
Biochem Pharmacol; 2018 Jan; 147():153-169. PubMed ID: 29155148
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors.
Hoestgaard-Jensen K; Dalby NO; Wolinsky TD; Murphey C; Jones KA; Rottländer M; Frederiksen K; Watson WP; Jensen K; Ebert B
Neuropharmacology; 2010; 58(4-5):702-11. PubMed ID: 20060846
[TBL] [Abstract][Full Text] [Related]
5. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
6. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors.
Feng HJ; Jounaidi Y; Haburcak M; Yang X; Forman SA
Br J Pharmacol; 2014 Feb; 171(3):789-98. PubMed ID: 24199598
[TBL] [Abstract][Full Text] [Related]
7. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
8. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
[TBL] [Abstract][Full Text] [Related]
9. 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes.
Hall BJ; Chebib M; Hanrahan JR; Johnston GA
Eur J Pharmacol; 2005 Apr; 512(2-3):97-104. PubMed ID: 15840393
[TBL] [Abstract][Full Text] [Related]
10. The Direct Actions of GABA, 2'-Methoxy-6-Methylflavone and General Anaesthetics at β3γ2L GABAA Receptors: Evidence for Receptors with Different Subunit Stoichiometries.
Chua HC; Absalom NL; Hanrahan JR; Viswas R; Chebib M
PLoS One; 2015; 10(10):e0141359. PubMed ID: 26496640
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
12. The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor.
McGurk KA; Pistis M; Belelli D; Hope AG; Lambert JJ
Br J Pharmacol; 1998 May; 124(1):13-20. PubMed ID: 9630337
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes.
Hammer H; Ebert B; Jensen HS; Jensen AA
PLoS One; 2015; 10(3):e0120239. PubMed ID: 25798598
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic pain.
Johnstone TBC; Xie JY; Qu C; Wasiak DJ; Hogenkamp DJ; Porreca F; Gee KW
Pain; 2019 Jan; 160(1):198-209. PubMed ID: 30204648
[TBL] [Abstract][Full Text] [Related]
15. The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors.
Hoestgaard-Jensen K; O'Connor RM; Dalby NO; Simonsen C; Finger BC; Golubeva A; Hammer H; Bergmann ML; Kristiansen U; Krogsgaard-Larsen P; Bräuner-Osborne H; Ebert B; Frølund B; Cryan JF; Jensen AA
Br J Pharmacol; 2013 Oct; 170(4):919-32. PubMed ID: 23957253
[TBL] [Abstract][Full Text] [Related]
16. Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABA
Maramai S; Benchekroun M; Ward SE; Atack JR
J Med Chem; 2020 Apr; 63(7):3425-3446. PubMed ID: 31738537
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.
Maksay G; Thompson SA; Wafford KA
Br J Pharmacol; 2000 Apr; 129(8):1794-800. PubMed ID: 10780988
[TBL] [Abstract][Full Text] [Related]
18. GABAA receptor modulation by the novel intravenous general anaesthetic E-6375.
Pau D; Belelli D; Callachan H; Peden DR; Dunlop JI; Peters JA; Guitart X; Gutierrez B; Lambert JJ
Neuropharmacology; 2003 Dec; 45(8):1029-40. PubMed ID: 14614946
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
Varagic Z; Wimmer L; Schnürch M; Mihovilovic MD; Huang S; Rallapalli S; Cook JM; Mirheydari P; Ecker GF; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):371-83. PubMed ID: 23472852
[TBL] [Abstract][Full Text] [Related]
20. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
Olsen RW
Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
